Uloric (febuxostat) Guidelines

Uloric is a mainstream alternative to allopurinol for lowering uric acid to fix your gout.
Uloric’s generic name is febuxostat.

Launched in Europe and elsewhere in 2008 as Adenuric, early 2009 saw FDA approval of this gout medication in the USA, as Uloric. It is also now available as Atenurix in the Philippines, and possibly India where Ajanta Pharma Limited has febuxostat manufacturing facilities.

Uloric has, like all new drugs, been subject to extensive testing [1]. Of course, allopurinol has been tested in real life for over 40 years and is generally well tolerated. If you are one of the few who cannot tolerate allopurinol, then febuxostat may well be your best way to reduce uric acid to a safe level.

Research continues into the long term effects of febuxostat around the world, and I’ll post new information here as it becomes available. It is also discussed frequently in the gout cures forum, so you can see the real-life experiences of other gout patients. Search for febuxostat OR Uloric OR Adenuric to get the latest views. Just copy the search query in italics into the search box at the top of the page.

Febuxostat Side-Effects

Please be aware that side effects are rarely worse than the terrible effects of untreated high uric acid. However, it pays to be aware of side effects so that you can know what to watch for, and when to consult your doctor.

For up-to-date information about potential adverse events, please see Uloric side effects

Uloric Chemical Structure Image. This equation for febuxostat is part of the 2012 prescribing information for Uloric. This update includes the liver warnings.

Uloric: Next Steps

Being a new drug, there is still lots of ongoing research. I will report these back as amendments to this febuxostat part of the Gout Treatments section, or as febuxostat news articles.

If you have experienced either Uloric or Adenuric, or if you have questions about this gout medication, please ask in the gout forum.

Uloric: References

  1. Author:
    Takeda Pharmaceuticals North America, Inc.
    Briefing Document for Febuxostat.
    Nov 2008.
    Full Report:
    Febuxostat Briefing Material

Related Gout Facts: , ,

Please Like GoutPal on Facebook
Please Share This Page

What do you think about this page?

Did this page help you? If yes, please consider a small donation. Your donations help keep GoutPal's gout support services free for everyone. Please click to donate:

If not, please tell me how I can improve it to help you more.

Please note that my Feedback Form does not yet work on the current version of this website. So please send your feedback:

More Stories

Medical Disclaimer: The pupose of GoutPal is to provide jargon-free explanations of medical gout-related terms and procedures. Because gout sufferers need to know what questions to ask their doctor. Also, you need to understand what your doctor tells you. So this website explains gout science. But it is definitely NOT a substitute for medical advice.

Information on this website is provided by a fellow gout sufferer (Keith Taylor) with an accountant's precision for accurate data. But no medical qualifications. So you must seek professional medical advice about gout and any other health matters.

Google Gout

Type your question, or gout topic, in the search box. Or see Better Desktop Gout Search.